UK health data groups prepare bids for NHS contract as Palantir faces new tender
British technology and healthcare groups are positioning to challenge Palantir for the NHS Federated Data Platform contract as ministers prepare a new procurement process for the work. The government is expected to keep the current agreement in place rather than use a break clause by March, while opening the £330 million contract to bids under terms intended to favour UK suppliers.
Highlights
- UK ministers are launching a new procurement process for the NHS Federated Data Platform contract, opening opportunities for domestic suppliers to take over from Palantir.
- The Drystone Health AI Collaboration, comprising over 20 British-led companies including Voror Health Technologies and Black Pear Software, formally announced its bid for the contract.
- Political and union pressure over data sovereignty is intensifying, with groups like Unison urging ministers to replace Palantir due to performance and ethical concerns.
New tender process reshapes NHS contract race
As first reported by the Financial Times, ministers are setting up a procurement process that could allow a British supplier to take over management of the NHS Federated Data Platform, a system designed to combine patient data from different parts of the health service to improve efficiency.At least two rival groups are preparing bids. A British-led consortium of more than 20 companies, Drystone Health AI Collaboration, said on Monday that it would bid for the contract, with Temple Black chief Shane Tickell arguing Palantir does not provide good value for the NHS.
The consortium includes Voror Health Technologies and Black Pear Software, both previous bidders for the platform contract, as well as the UK arm of Toronto-listed VitalHub and IMS Maxims, a subsidiary of TSX-listed Constellation Software. Tickell said the group is larger and better capitalised than earlier UK-led efforts.
London-based Quantexa is also understood to be preparing a fresh bid after losing out when the contract was awarded three years ago. The company is viewed as a leading contender if the government opts for a British firm, supported by its NHS work in Cheshire and Merseyside and by its 2023 bid, and it is also said to be open to a model in which different companies manage different parts of the platform.
Political pressure builds over data sovereignty
Palantir may still seek to retain the contract by arguing it should count as a UK company because staff working on the NHS project are based in Britain. Ministers are working on a new definition of a "UK supplier" for procurement purposes that is expected to be ready before the formal start of the NHS process.Oracle Health, the healthcare arm of Oracle, is also seen as a potential bidder after reaching the final stage of the 2023 process. Like other non-UK groups, it would face scrutiny over whether it strengthens British sovereignty in health technology.
The contract review comes amid mounting criticism from activists, Labour MPs and healthcare professionals over the government's agreement with Palantir, which is known for work with U.S. immigration enforcement and Israeli military intelligence. Unison, the UK's largest public sector union, said NHS members using the platform are not satisfied with its performance and is urging ministers to back a domestic alternative.
Andrea Egan, Unison's general secretary, described the platform as "both technically and ethically bankrupt" and said ministers should invest in NHS expertise rather than hand sensitive data to a private American company. Oracle Health did not respond to a request for comment, Quantexa declined to comment, and Palantir also declined to comment.
We have also looked at Zetrix AI debt crisis, highlighting governance lapses and mounting risks for investors and creditors.